The North America Tendon Allograft Market is projected to witness market growth of 4.4% CAGR during the forecast period (2024-2031).
The US market dominated the North America Tendon Allograft Market, by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $9.32 billion by 2031. The Canada market is exhibiting a CAGR of 6.6% during (2024 - 2031). Additionally, The Mexico market is projected to experience a CAGR of 5.7% during (2024 - 2031).
Tendon allografts are biological tissues derived from human donors, used to repair or reconstruct damaged patient tendons. Unlike autografts, which involve taking tissue from the patient’s body, or synthetic implants, tendon allografts are sourced from deceased or living donors who have consented to tissue donation. These allografts undergo rigorous screening, processing, and sterilization to ensure they are safe and effective for medical use.
The market has emerged as a vital segment within the broader orthopedic and medical devices industry, reflecting significant advancements in medical technology and surgical practices. This market is gaining momentum due to a combination of factors, including advancements in surgical techniques, increasing incidence of sports injuries, a growing aging population, and a rising preference for biologic solutions over synthetic options. In addition, the expansion of the market is made possible by the developing healthcare infrastructure in emerging markets as well as the growing knowledge of the benefits of tendon allografts among both members of the medical community and patients.
In Mexico, the rise in sports participation and related injuries boosts the demand for tendon allografts. The Mexican Ministry of Health reports that sports injuries are a leading cause of musculoskeletal issues in the country, with a significant number involving tendon damage. Soccer, the most popular sport in Mexico, accounts for a substantial portion of these injuries. The growing adoption of tendon allografts in orthopedic surgeries, supported by the increasing number of trained orthopedic surgeons and advancements in medical facilities, propels the demand for tendon allografts in Mexico. Therefore, the region will present lucrative growth opportunities for the regional market.
The US market dominated the North America Tendon Allograft Market, by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $9.32 billion by 2031. The Canada market is exhibiting a CAGR of 6.6% during (2024 - 2031). Additionally, The Mexico market is projected to experience a CAGR of 5.7% during (2024 - 2031).
Tendon allografts are biological tissues derived from human donors, used to repair or reconstruct damaged patient tendons. Unlike autografts, which involve taking tissue from the patient’s body, or synthetic implants, tendon allografts are sourced from deceased or living donors who have consented to tissue donation. These allografts undergo rigorous screening, processing, and sterilization to ensure they are safe and effective for medical use.
The market has emerged as a vital segment within the broader orthopedic and medical devices industry, reflecting significant advancements in medical technology and surgical practices. This market is gaining momentum due to a combination of factors, including advancements in surgical techniques, increasing incidence of sports injuries, a growing aging population, and a rising preference for biologic solutions over synthetic options. In addition, the expansion of the market is made possible by the developing healthcare infrastructure in emerging markets as well as the growing knowledge of the benefits of tendon allografts among both members of the medical community and patients.
In Mexico, the rise in sports participation and related injuries boosts the demand for tendon allografts. The Mexican Ministry of Health reports that sports injuries are a leading cause of musculoskeletal issues in the country, with a significant number involving tendon damage. Soccer, the most popular sport in Mexico, accounts for a substantial portion of these injuries. The growing adoption of tendon allografts in orthopedic surgeries, supported by the increasing number of trained orthopedic surgeons and advancements in medical facilities, propels the demand for tendon allografts in Mexico. Therefore, the region will present lucrative growth opportunities for the regional market.
List of Key Companies Profiled
- INTEGRA LIFESCIENCES HOLDINGS CORPORATION
- Conmed Corporation
- RTI Surgical, Inc.
- Arthrex, Inc.
- Organogenesis Holdings, Inc.
- Zimmer Biomet Holdings, Inc.
- B.Braun Melsungen AG (Aesculap, Inc.)
- Stryker Corporation
- MIMEDX Group, Inc.
Market Report Segmentation
By End User- Hospitals
- Orthopedic Clinics
- Others
- Patellar Tendon
- Tibialis
- Achilles Tendon
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Tendon Allograft Market, by End User
Chapter 5. North America Tendon Allograft Market, by Product Type
Chapter 6. North America Tendon Allograft Market, by Country
Chapter 7. Company Profiles
Companies Mentioned
- INTEGRA LIFESCIENCES HOLDINGS CORPORATION
- Conmed Corporation
- RTI Surgical, Inc.
- Arthrex, Inc.
- Organogenesis Holdings, Inc.
- Zimmer Biomet Holdings, Inc.
- B. Braun Melsungen AG (Aesculap, Inc.)
- Stryker Corporation
- MIMEDX Group, Inc.
Methodology
LOADING...
